ArticleCancer chemotherapy and pharmacology2022

Drug resistance to nelarabine in leukemia cell lines might be caused by reduced expression of deoxycytidine kinase through epigenetic mechanisms.

Keishi Yoshida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.